Gossamer Bio submitted an FDA application for approval of seralutinib, an inhaled therapy for adults with pulmonary arterial ...

New clinical trial data from HYPERION are now included in Winrevair’s label, which also adds a contraindication for serious ...

Measurements that look at the interplay between the pulmonary arteries and the heart may help predict mortality risk in PH.

A national database study found wide variation in drug treatment for adults with PAH who presented with shock.

After five years of raising rare disease awareness, columnist Anna Jeter is retiring "Blooming Hope" and says farewell to her ...

A pulmonary hypertensive crisis is a sudden episode of physical stress that causes a sharp, dangerous increase in blood pressure in the lungs of a person with pulmonary hypertension (PH). This can ...

Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the blood vessels that transport blood from the heart to the lungs. In PH, the pulmonary ...

Pulmonary hypertension (PH) is a disease characterized by high blood pressure in the blood vessels, called the pulmonary arteries, responsible for transporting blood from the heart to the lungs.

What is Winrevair for pulmonary arterial hypertension? Winrevair (sotatercept-csrk) is an injection therapy for adults with pulmonary arterial hypertension (PAH), approved in the U.S. to improve ...

Pulmonary hypertension is a chronic and progressive disease characterized by high blood pressure in the pulmonary arteries, the blood vessels of the lungs. There are many potential causes of the ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...